HIV Mutation Detail Information

Virus Mutation HIV Mutation R178G


Basic Characteristics of Mutations
Mutation Site R178G
Mutation Site Sentence The SERINC5-incorporated Nef recombinant viruses carrying subtype B Nef with a V16I, E63G, A83G, R105K, D108E, R178G, or E179N mutation or subtype C Nef with a G63E, F81Y, A83G, or D108E mutation were significantly less infectious compared with the virus with the corresponding wildtype Nef (Fig. 3c and d).
Mutation Level Amino acid level
Mutation Type Nonsynonymous substitution
Gene/Protein/Region Nef
Standardized Encoding Gene Nef  
Genotype/Subtype HIV-1 B
Viral Reference HXB2
Functional Impact and Mechanisms
Disease HIV Infections    
Immune -
Target Gene SERINC5   
Clinical and Epidemiological Correlations
Clinical Information -
Treatment -
Location Los Alamos
Literature Information
PMID 39612239
Title Functional variability of Nef in antagonizing SERINC5 during acute to chronic HIV-1 infection
Author Li W,Li G,Liu Y,Meng L,Zhang T,Wang L,Li H,Yu B,Wu J,Wang C,Yu X
Journal AIDS (London, England)
Journal Info 2025 Mar 1;39(3):229-240
Abstract OBJECTIVE: The ability of HIV-1 Nef to counteract the host restriction factor SERINC5 and enhance virion infectivity has been well established. However, the impact of long-term within-host Nef evolution on this antagonistic capability remains unclear. DESIGN: Analysis of longitudinal activity of Nef in antagonizing SERINC5. METHODS: We investigated the downregulation activity of Nef against SERINC5 at different stages of infection by analyzing the cognate transmitted/founder, set point, and/or chronic Nef isolates from a cohort of 19 people with either subtype B or C HIV-1. RESULTS: The Nef isolates from different stages exhibited varying abilities to antagonize SERINC5. Long-term evolution resulted in mutations accumulated in Nef and a decline of Nef-mediated SERINC5 downregulation function in subtype B, but not in subtype C viruses, leading to a rapid reduction in viral load from peak viremia. Furthermore, we identified four polymorphisms of both subtype B and C Nef that are associated with variations in the SERINC5 antagonistic function and viral infectivity. HIV-1 NL4-3 variants encoding Nef E63G, A83G, R105K, or D108E mutants exhibited reduced replication capacity through a SERINC5-dependent mechanism. However, among different subjects, only a small part of naturally occurring mutations at these sites were selected by host T-cell responses, suggesting a limited impact of host T-cell responses on influencing Nef's ability to antagonize SERINC5. CONCLUSION: These results highlight the potential contribution of functional variation in Nef to differences in HIV-1 pathogenesis and provide significant implications for understanding the evolutionary interaction between Nef and SERINC5 in vivo .
Sequence Data -
Mutation Information
Note
Basic Characteristics of Mutations
  • Mutation Site: The specific location in a gene or protein sequence where a change occurs.
  • Mutation Level: The level at which a mutation occurs, including the nucleotide or amino acid level.
  • Mutation Type: The nature of the mutation, such as missense mutation, nonsense mutation, synonymous mutation, etc.
  • Gene/Protein/Region: Refers to the specific region of the virus where the mutation occurs. Including viral genes, viral proteins, or a specific viral genome region. If the article does not specifically indicate the relationship between the mutation and its correspondence, the main
  • Gene/Protein/Region studied in the article is marked.
  • Genotype/Subtype: Refers to the viral genotype or subtype where the mutation occurs. If the article does not specifically indicate the relationship between the mutation and its correspondence, the main Genotype/Subtype studied in the article is marked.
  • Viral Reference: Refers to the standard virus strain used to compare and analyze viral sequences.
Functional Impact and Mechanisms
  • Disease: An abnormal physiological state with specific symptoms and signs caused by viral infection.
  • Immune: The article focuses on the study of mutations and immune.
  • Target Gene: Host genes that viral mutations may affect.
Clinical and Epidemiological Correlations
  • Clinical Information: The study is a clinical or epidemiological study and provides basic information about the population.
  • Treatment: The study mentioned a certain treatment method, such as drug resistance caused by mutations. If the study does not specifically indicate the relationship between mutations and their correspondence treatment, the main treatment studied in the article is marked.
  • Location: The source of the research data.
Literature Information
  • Sequence Data: The study provides the data accession number.